Bibliografía del artículo
1. MacLennan R, Green AC, McLeod GR, Martin NG. Increasing incidence of cutaneous melanoma in Queensland, Australia. J Natl Cancer Inst 84:1427-32, 1992.
2. Lázaro Ochaita P, Avilés Izquierdo JA. Epidemiología del melanoma cutáneo. Clínicas Dermatológicas de la AEDV, 2003.
3. Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol 146(Supl.6)1:1-6, 2002.
4. Bevona C, Sober AJ. Melanoma incidence trends. Dermatol Clin 20:589-95, vii, 2002.
5. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19:3635-48, 2001.
6. Weinstock MA. Issues in the epidemiology of melanoma. Hematol Oncol Clin North Am 12:681-98, 1998.
7. Garbe C, McLeod GR, Buettner PG. Time trends of cutaneous melanoma in Queensland, Australia and Central Europe. Cancer 89:1269-78, 2000.
8. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 83:1664-78, 1998.
9. Sturm RA. Skin colour and skin cancer - MC1R, the genetic link. Melanoma Res 2002; 12:405-16. Cooperative Study. Br J Dermatol 142:893-8, 2000.
10. Rodríguez Blas MC. Cancer de piel. Ministerio de Sanidad y Consumo, Subdirección General de Epidemiología, Promoción y Educación para la Salud. Madrid, 1999.
11. Ocana-Riola R, Martínez-García C, Serrano S, Buendía-Eisman A, Ruiz-Baena C, Canela-Soler J. Population-based study of cutaneous malignant melanoma in the Granada province (Spain), 1985-1992. Eur J Epidemiol 17:169-74, 2001.
12. Serrano S. Incidencia de melanoma en España. Registro Nacional de Melanomas. Libro de Resúmenes XXVII Congreso Nacional de Dermatología y Venereología. Santander, 32-33, 1998.
13. Academia Española de Dermatología y Venereología A. Registro Nacional de Melanoma.
14. Burton RC, Armstrong BK. Current melanoma epidemic: a nonmetastasizing form of melanoma? World J Surg 19:330-3, 1995.
15. Rees JL. The melanoma epidemic: reality and artefact. BMJ 312:137-8, 1996.
16. Swerlick RA, Chen S. The melanoma epidemic: more apparent than real? Mayo Clin Proc 72:559-64, 1997.
17. Horn-Ross PL, Holly EA, Brown SR, Aston DA. Temporal trends in the incidence of cutaneous malignant melanoma among Caucasians in the San Francisco-Oakland MSA. Cancer Causes Control 2:299-305, 1991.
18. Van der Esch EP, Muir CS, Nectoux J, Macfarlane G, Maisonneuve P, Bharucha H, et al. Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely. Int J Cancer 47:483-9, 1991.
19. Dennis LK. Analysis of the melanoma epidemic, both apparent and real: data from the 1973 through 1994 surveillance, epidemiology, and end results program registry. Arch Dermatol 135:275-80, 1999.
20. Sim FH, Nelson TE, Pritchard DJ. Malignant melanoma: Mayo Clinic experience. Mayo Clin Proc 72:565-9, 1997.
21. Lens MB, Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 150:179-85, 2004.
22. Giles GG, Armstrong BK, Burton RC, Staples MP, Thursfield VJ. Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994. BMJ 312:1121-5, 1996.
23. La Vecchia C, Lucchini F, Negri E, Levi F. Recent declines in worldwide mortality from cutaneous melanoma in youth and middle age. Int J Cancer 81:62-6, 1999.
24. Balzi D, Carli P, Giannotti B, Paci E, Buiatti E. Cutaneous melanoma in the Florentine area, Italy: incidence, survival and mortality between 1985 and 1994. Eur J Cancer Prev 12:43-8, 2003.
25. Jemal A, Devesa SS, Fears TR, Hartge P. Cancer surveillance series: changing patterns of cutaneous malignant melanoma mortality rates among whites in the United States. J Natl Cancer Inst 92:811-8, 2000.
26. Kolmel KF, Kulle B, Lippold A, Seebacher C. Survival probabilities and hazard functions of malignant melanoma in Germany 1972-1996, an analysis of 10433 patients. Evolution of gender differences and malignancy. Eur J Cancer 38:1388-94, 2002.
27. Edwards BK, Howe HL, Ries LA, Thun MJ, Rosenberg HM, Yancik R, et al. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer 94:2766-92, 2002.
28. Coleman MP, Esteve J, Damiecki P, Arslan A, Renard H. Trends in cancer incidence and mortality. IARC Sci Publ 1-806, 1993.
29. González Arráez JI, Alfonso Sánchez JL, Jiménez Fernández FJ, Gil Mary A. Melanoma maligno de piel: Estudio de la mortalidad y principales factores de riesgo. España 1951-1983. Actas Dermo-Sif 80:33-9, 1989.
30. Nieto A, Ruiz-Ramos M, Abdel-Kader L, Conde M, Camacho F. Gender differences in rising trends in cutaneous malignant melanoma in Spain, 1975-98. Br J Dermatol 148:110-6, 2003.
31. Ries LA, Wingo PA, Miller DS, Howe HL, Weir HK, Rosenberg HM, et al. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer 88:2398-424, 2000.
32. MacKie RM, Hole D, Hunter JA, Rankin R, Evans A, McLaren K, et al. Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. The Scottish Melanoma Group. BMJ 315:1117-21, 1997.
33. Marks R. The changing incidence and mortality of melanoma in Australia. Recent Results Cancer Res 160:113-21, 2002.
34. MacKie RM, Bray CA, Leman JA. Effect of public education aimed at early diagnosis of malignant melanoma: cohort comparison study. BMJ 326:367, 2003.
35. Swerlick RA, Chen S. The melanoma epidemic. Is increased surveillance the solution or the problem? Arch Dermatol 132:881-4, 1996.
36. Rigel DS. Malignant melanoma: incidence issues and their effect on diagnosis and treatment in the 1990s. Mayo Clin Proc 72:367-71, 1997.
37. Balzi D, Carli P, Giannotti B, Buiatti E. Skin melanoma in Italy: a population-based study on survival and prognostic factors. Eur J Cancer 34:699-704, 1998.
38. Levi F, Randimbison L, La Vecchia C, Te VC, Franceschi S. Prognostic factors for cutaneous malignant melanoma in Vaud, Switzerland. Int J Cancer 78:315-9, 1998.